TerraBioForge develops advanced synthetic biology platforms for designing and engineering novel microbial systems. The company focuses on creating custom biomanufacturing solutions to produce sustainable chemicals and materials. Their technology enables precise genetic modification for optimized industrial fermentation processes.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The vast potential of microbial natural products remains largely untapped due to the challenge of activating cryptic or silent biosynthetic gene clusters within microorganisms. Traditional methods struggle to efficiently produce these compounds, hindering drug discovery and development efforts.
Solution
Terra Bioforge employs proprietary technology to unlock and activate these cryptic biosynthetic gene clusters, enabling scalable and efficient production of microbial natural products. By accessing previously inaccessible natural compounds, Terra Bioforge expands the chemical space available for drug discovery. Their approach overcomes limitations in traditional natural product research, providing a platform for identifying and producing novel compounds with therapeutic potential. This technology facilitates the exploration of nature's chemistry, accelerating the discovery and development of new drugs and other valuable products.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and research institutions involved in drug discovery and development, as well as those interested in exploring the potential of microbial natural products.
Features
- Proprietary technology for activating cryptic biosynthetic gene clusters
- Enhanced production of microbial natural products
- Scalable production processes for efficient compound generation
- Access to a wider range of natural compounds for drug discovery